Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial

DSpace Repository

Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial

Author: Pouyiourou, Maria; Kraft, Bianca N.; Wohlfromm, Timothy; Stahl, Michael; Kubuschok, Boris; Loeffler, Harald; Hacker, Ulrich T.; Huebner, Gerdt; Weiss, Lena; Bitzer, Michael; Ernst, Thomas; Schuett, Philipp; Hielscher, Thomas; Delorme, Stefan; Kirchner, Martina; Kazdal, Daniel; Ball, Markus; Kluck, Klaus; Stenzinger, Albrecht; Bochtler, Tilmann; Kraemer, Alwin
Tübinger Autor(en):
Bitzer, Michael
Published in: Nature Communications (2023), Bd. 14 (1), Article 6761
Verlagsangabe: Berlin : Nature Portfolio
Language: English
Full text: http://dx.doi.org/10.1038/s41467-023-42400-5
ISSN: 2041-1723
DDC Classifikation: 500 - Natural sciences and mathematics
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)